Carol K. Kasper

4.7k citations

103 papers · 3.7k indexed · 1 hit paper · h-index 32

Hematology top 0.2%
Genetics top 1%
Molecular Biology top 10%
Surgery
Genetics top 10%

Co-authors: Louis M. Aledort Peter H. Levine Joseph C. Fratantoni Jan van Eys Jack Lazerson Campbell W. McMillan Jeanne M. Lusher Sandor S. Shapiro
Topics: Hemophilia Treatment and Research (81 papers)Blood Coagulation and Thrombosis Mechanisms (25 papers)Chronic Myeloid Leukemia Treatments (21 papers)
Cited by: Hematology Genetics Hepatology
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Italy United Kingdom

In The Last Decade

Carol K. Kasper

97 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A More Uniform Measurement of Factor VIII Inhibitors

1975 513 citations Carol K. Kasper, Louis M. Aledort et al. Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Carol K. Kasper

Since Specialization

Citations

This map shows the geographic impact of Carol K. Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol K. Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol K. Kasper more than expected).

Fields of papers citing papers by Carol K. Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol K. Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol K. Kasper. The network helps show where Carol K. Kasper may publish in the future.

Co-authorship network of co-authors of Carol K. Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Carol K. Kasper. A scholar is included among the top collaborators of Carol K. Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol K. Kasper. Carol K. Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of sporadic and familial haemophilia 2006 ·Haemophilia ·Carol K. Kasper,Julie Lin	51
2	Products for Clotting Factor Replacement in Developing Countries 2005 ·Seminars in Thrombosis and Hemostasis ·Carol K. Kasper	13
3	Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience 2002 ·Haemophilia ·Donna DiMichele,(unknown),Carol K. Kasper,P.M. Mannucci,Elena Santagostino,C. R. M. Hay	4
4	Frequency of recent retrotransposition events in the human factor IX gene 2001 ·Human Mutation ·Xuemin Li,William A. Scaringe,Kathleen A. Hill,Stacy Roberts,April Mengos,(unknown),(unknown),Carol K. Kasper,Steve S. Sommer	55
5	Continuous infusion of porcine factor VIII in patients with haemophilia A and high‐responding inhibitors: stability and clinical experience 2001 ·Haemophilia ·Peter O’Gorman,Donna DiMichele,Carol K. Kasper,Pier Mannuccio Mannucci,(unknown),C. R. M. Hay	11
6	Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans 2000 ·Human Mutation ·Joni B. Drost,William A. Scaringe,Ana Rebeca Jaloma‐Cruz,Xuemin Li,(unknown),Carol K. Kasper,Steve S. Sommer	7
7	Human Factor VIII for Bleeding in Patients with Inhibitors 1999 ·Vox Sanguinis ·Carol K. Kasper	0
8	Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations 1999 ·Human Mutation ·Rhett P. Ketterling,Joni B. Drost,William A. Scaringe,(unknown),Jingzhong Liu,Carol K. Kasper,Steve S. Sommer	41
9	In vivo recovery and early half‐life of infused factor VIII in haemophilia A 1995 ·Haemophilia ·Carol K. Kasper	4
10	Two novel factor IX promoter mutations: incremental progress towards ‘saturation in vivo mutagenesis’ of a human promoter region 1995 ·Human Molecular Genetics ·Rhett P. Ketterling,(unknown),(unknown),Carol K. Kasper,(unknown),(unknown),Steve S. Sommer	10
11	Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII 1993 ·The Lancet ·Joseph E. Addiego,Carol K. Kasper,C F Abildgaard,M W Hilgartner,Jeanne M. Lusher,Bertil Glader,Louis M. Aledort	136
12	Comparison of the behavior of normal factor IX and the factor IX BM variant hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources 1993 ·American Journal of Hematology ·Jerry B. Lefkowitz,Dougald M. Monroe,Carol K. Kasper,Harold R. Roberts	5
13	Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee 1993 ·Transfusion ·Carol K. Kasper,Jeanne M. Lusher	44
14	Hemophilia in the 1990s: Principles of Management and Improved Access to Care 1992 ·Seminars in Thrombosis and Hemostasis ·Carol K. Kasper,Pier Mannuccio Mannucci,(unknown),Doreen B. Brettler,Ampaiwan Chuansumrit,(unknown),(unknown),P. B. A. Kernoff,I. R. Peake,K.A. Rickard,Sam Schulman,Cees Th. Smit Sibinga	15
15	Complications of Hemophilia A Treatment: Factor VIII Inhibitorsa 1991 ·Annals of the New York Academy of Sciences ·Carol K. Kasper	17
16	Haemophilia in the 1990s: Report of a Joint Meeting of the World Health Organization and World Federation of Hemophilia 1991 ·Vox Sanguinis ·Carol K. Kasper,Pier Mannuccio Mannucci,(unknown),Doreen B. Brettler,Ampaiwan Chuansumrit,L. Heijnen,(unknown),(unknown),I. R. Peake,K.A. Rickard,(unknown),C. Th. Smit Sibinga	6
17	Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A 1990 ·New England Journal of Medicine ·Richard S. Schwartz,Charles F. Abildgaard,Louis M. Aledort,Steven Arkin,A. L. Bloom,H.‐H. Brackmann,Doreen B. Brettler,Hiromu Fukui,Margaret W. Hilgartner,Martin J. Inwood,Carol K. Kasper,P. B. A. Kernoff,Peter H. Levine,Jeanne M. Lusher,Pier Mannuccio Mannucci,I. Scharrer,(unknown),(unknown),(unknown),Randy Allred	185
18	Restriction endonuclease mapping of six novel deletions of the factor VIII gene in hemophilia A 1988 ·Human Genetics ·Hagop Youssoufian,Carol K. Kasper,Deborah G. Phillips,Haig H. Kazazian,Stylianos E. Antonarakis	13
19	Hemophilia B: Genetic Variants and Carrier Detection 1977 ·Thrombosis and Haemostasis ·Carol K. Kasper,Bjarne Østerud,Samuel I. Rapaport	2
20	Red Cell Values in Healthy Adolescents 1966 ·American Journal of Clinical Nutrition ·Carol K. Kasper,Ralph O. Wallerstein	4

About Carol K. Kasper

Carol K. Kasper is a scholar working on Hematology, Genetics and Transplantation, having authored 103 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (81 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers) and Chronic Myeloid Leukemia Treatments (21 papers). The work is most often cited by research in Hematology (3.0k citations), Genetics (862 citations) and Hepatology (106 citations). Carol K. Kasper has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Louis M. Aledort, Peter H. Levine, Joseph C. Fratantoni, Jan van Eys, Jack Lazerson, Campbell W. McMillan, Jeanne M. Lusher, Sandor S. Shapiro, Samuel I. Rapaport and Stylianos E. Antonarakis. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact